CPRX Q1 2025 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$141M+43.6% YoY

Gross Profit

$124M87.3% margin

Operating Income

$63M44.8% margin

Net Income

$57M40.1% margin

EPS (Diluted)

$0.45

QoQ Revenue Growth

-0.3%

Cash Flow

Operating Cash Flow

$60M

Free Cash Flow

$60M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$909M

Total Liabilities

$115M

Stockholders' Equity

$794M

Cash & Equivalents

$581M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$99M	+43.6%
Gross Profit	$124M	$86M	+43.6%
Operating Income	$63M	$27M	+133.6%
Net Income	$57M	$23M	+143.8%

Revenue Segments

Product Revenue Net

$141M100%

License And Other Revenue

$21,0000%